✦ LIBER ✦

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens

✍ Scribed by Saarto, T; Blomqvist, C; Välimäki, M; Mäkelä, P; Sarna, S; Elomaa, I

Book ID: 109837353
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 640 KB
Volume: 75
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1997.105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone mineral density in women with breas

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

✍ Richard R. Love; Richard B. Mazess; Douglass C. Tormey; Howard S. Barden; Polly 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 398 KB

Bone mineral density loss during adjuvan

Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

✍ David A. Cameron; Sharon Douglas; Janet E. Brown; Richard A. Anderson 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 252 KB

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Matthew Goetz; Vera Suman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

The study by Okishiro et al 1 concludes that the cytochrome P450 (CYP) genotype CYP2D6\*10/\*10 is unlikely to have a clinically significant impact on prognosis in women with breast cancer who receive adjuvant tamoxifen. However, several aspects of the study by Okishiro et al call their conclusions

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Masatsugu Okishiro; Tetsuya Taguchi; Seung Jin Kim; Kenzo Shimazu; Yasuhiro Tama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

Reply to Genetic polymorphisms of CYP2D6

Reply to Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Shinzaburo Noguchi; Masatsugu Okishiro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

Bone Mineral Density and Lipid Changes D

Bone Mineral Density and Lipid Changes During 5 Years of Follow-up in a Study of Prevention of Breast Cancer with Toremifene in Healthy, High-risk Pre- and Post-menopausal Women

✍ R. Erkkola; L. Mattila; T. Powles; J. Heikkinen; B. Toivola; P. Korhonen; M. Mus 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 251 KB